🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher
DECIDER-2: Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy.
Europe PMCOriginal source






